Nabriva Therapeutics (NBRV) Stock Forecast, Price Target & Predictions
NBRV Stock Forecast
Nabriva Therapeutics stock forecast is as follows: an average price target of $1.00 (represents a 58.73% upside from NBRV’s last price of $0.63) and
NBRV Price Target
Nabriva Therapeutics Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jan 06, 2023 | Carl Byrnes | Northland Securities | $1.00 | $1.33 | -24.81% | 58.73% |
The latest Nabriva Therapeutics stock forecast, released on Jan 06, 2023 by Carl Byrnes from Northland Securities, set a price target of $1.00, which represents a -24.81% decrease from the stock price at the time of the forecast ($1.33), and a 58.73% increase from NBRV last price ($0.63).
Nabriva Therapeutics Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $0.63 | $0.63 | $0.63 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Nabriva Therapeutics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Nabriva Therapeutics's last price of $0.63. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Nabriva Therapeutics Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| NBRV | Nabriva Therapeutics | $1.42 | $1.00 | -29.58% | - |
| TRVN | Trevena | $5.95 | $3.50 | -41.18% | - |
NBRV Forecast FAQ
Will Nabriva Therapeutics stock go up soon?
According to Wall Street analysts' prediction for NBRV stock, the company can go up by 58.73% (from the last price of $0.63 to the average price target of $1), up by 58.73% based on the highest stock price target, and up by 58.73% based on the lowest stock price target.
Can Nabriva Therapeutics stock reach $1?
NBRV's average twelve months analyst stock price target of $1 does not support the claim that Nabriva Therapeutics can reach $1 in the near future.